An Informatics-based Approach to Identify Key Pharmacological Components in Drug-Drug Interactions

TL;DR

This study uses large-scale data and statistical methods to identify key pharmacological components that predict drug-drug interactions, offering a new perspective on evaluating drug safety.

Contribution

It introduces a data-driven approach combining feature selection and logistic regression to pinpoint key pharmacological components in DDIs, enhancing understanding of drug interaction mechanisms.

Findings

Top 10% features achieve similar classification accuracy as all features.

Key pharmacological components are identified and quantified by classifier coefficients.

The approach provides a novel way to evaluate pharmacological components in DDIs.

Abstract

Drug-drug interactions (DDI) can cause severe adverse drug reactions and pose a major challenge to medication therapy. Recently, informatics-based approaches are emerging for DDI studies. In this paper, we aim to identify key pharmacological components in DDI based on large-scale data from DrugBank, a comprehensive DDI database. With pharmacological components as features, logistic regression is used to perform DDI classification with a focus on searching for most predictive features, a process of identifying key pharmacological components. Using univariate feature selection with chi-squared statistic as the ranking criteria, our study reveals that top 10% features can achieve comparable classification performance compared to that using all features. The top 10% features are identified to be key pharmacological components. Furthermore, their importance is quantified by feature coefficients in the classifier, which measures the DDI potential and provides a novel perspective to evaluate pharmacological components.